The use of kisspeptin as a novel physiological oocyte maturation trigger for patients undergoing IVF treatment
Background: Patients with inactivating mutations in kisspeptin signalling are infertile. Kisspeptin-54, the major circulating isoform of kisspeptin in humans, potently stimulates reproductive hormone secretion in humans. Animal studies suggest that kisspeptin is involved in the generation of the lut...
Main Author: | Christopoulos, Georgios |
---|---|
Other Authors: | Dhillo, Waljit |
Published: |
Imperial College London
2015
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.749051 |
Similar Items
-
The use of kisspeptin as a novel physiological trigger for oocyte maturation in IVF treatment
by: Islam, Rumana
Published: (2017) -
OOCYTE FINAL MATURATION TRIGGERS IN IVF PROGRAMS
by: E. B. Rudakova
Published: (2016-12-01) -
Endocrine Requirements for Oocyte Maturation Following hCG, GnRH Agonist, and Kisspeptin During IVF Treatment
by: Ali Abbara, et al.
Published: (2020-10-01) -
Effect of kisspeptin on in vitro maturation of sheep oocytes
by: Priyanka Byri, et al.
Published: (2017-03-01) -
CoQ10 Supplementation in Patients Undergoing IVF-ET: The Relationship with Follicular Fluid Content and Oocyte Maturity
by: Stefano Raffaele Giannubilo, et al.
Published: (2018-10-01)